Quick Answer
Crinetics Pharmaceuticals, Inc. reported Common Stock Shares Outstanding of 95.58 million shares for the year ending 2025.
- Crinetics Pharmaceuticals, Inc. showed an increase of +2.9% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from Crinetics Pharmaceuticals, Inc.'s annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2017 to 2025 (10 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 10 years of available data (2017 to 2025), Crinetics Pharmaceuticals, Inc.'s Common Stock Shares Outstanding has grown by 6,067.8%.
- Historical annual values: Fiscal year 2025: 95.58 million shares | Fiscal year 2024: 92.93 million shares | Fiscal year 2023: 68.18 million shares | Fiscal year 2023: 32.34 million shares | Fiscal year 2022: 53.88 million shares | Fiscal year 2021: 47.60 million shares | Fiscal year 2020: 33.00 million shares | Fiscal year 2019: 24.26 million shares | Fiscal year 2018: 24,061 shares | Fiscal year 2017: 1.55 million shares.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: